IL17A and autoimmune hepatitis: Symptomology of AIH was shown to be decreased in TCDD treated mice, as measured by a decrease in ALT levels, decrease in cell infiltration, and decrease in the production of inflammatory cytokines such as IL-6 and IL-17, antiparallel to an increase in immunosuppressive cytokines such as IL-10.